[go: up one dir, main page]

DE102008063992A8 - New aliphatic substituted pyrazolopyridines and their use - Google Patents

New aliphatic substituted pyrazolopyridines and their use Download PDF

Info

Publication number
DE102008063992A8
DE102008063992A8 DE102008063992A DE102008063992A DE102008063992A8 DE 102008063992 A8 DE102008063992 A8 DE 102008063992A8 DE 102008063992 A DE102008063992 A DE 102008063992A DE 102008063992 A DE102008063992 A DE 102008063992A DE 102008063992 A8 DE102008063992 A8 DE 102008063992A8
Authority
DE
Germany
Prior art keywords
aliphatic substituted
new aliphatic
substituted pyrazolopyridines
pyrazolopyridines
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102008063992A
Other languages
German (de)
Other versions
DE102008063992A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Priority to DE102008063992A priority Critical patent/DE102008063992A1/en
Priority to JP2011541161A priority patent/JP5791110B2/en
Priority to CA2747305A priority patent/CA2747305C/en
Priority to ES09768334T priority patent/ES2414808T3/en
Priority to EP09768334.6A priority patent/EP2379071B1/en
Priority to US13/133,383 priority patent/US8334291B2/en
Priority to PCT/EP2009/008741 priority patent/WO2010078900A2/en
Publication of DE102008063992A1 publication Critical patent/DE102008063992A1/en
Publication of DE102008063992A8 publication Critical patent/DE102008063992A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE102008063992A 2008-12-19 2008-12-19 New aliphatic substituted pyrazolopyridines and their use Withdrawn DE102008063992A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE102008063992A DE102008063992A1 (en) 2008-12-19 2008-12-19 New aliphatic substituted pyrazolopyridines and their use
JP2011541161A JP5791110B2 (en) 2008-12-19 2009-12-08 Novel aliphatic substituted pyrazolopyridines and uses thereof
CA2747305A CA2747305C (en) 2008-12-19 2009-12-08 Novel aliphatically substituted pyrazolopyridines, and the use thereof
ES09768334T ES2414808T3 (en) 2008-12-19 2009-12-08 New aliphatically substituted pyrazolopyridines and their use
EP09768334.6A EP2379071B1 (en) 2008-12-19 2009-12-08 Novel aliphatically substituted pyrazolopyridines, and the use thereof
US13/133,383 US8334291B2 (en) 2008-12-19 2009-12-08 Aliphatically substituted pyrazolopyridines, and the use thereof
PCT/EP2009/008741 WO2010078900A2 (en) 2008-12-19 2009-12-08 Novel aliphatically substituted pyrazolopyridines, and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008063992A DE102008063992A1 (en) 2008-12-19 2008-12-19 New aliphatic substituted pyrazolopyridines and their use

Publications (2)

Publication Number Publication Date
DE102008063992A1 DE102008063992A1 (en) 2010-09-02
DE102008063992A8 true DE102008063992A8 (en) 2010-12-16

Family

ID=42316888

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102008063992A Withdrawn DE102008063992A1 (en) 2008-12-19 2008-12-19 New aliphatic substituted pyrazolopyridines and their use

Country Status (7)

Country Link
US (1) US8334291B2 (en)
EP (1) EP2379071B1 (en)
JP (1) JP5791110B2 (en)
CA (1) CA2747305C (en)
DE (1) DE102008063992A1 (en)
ES (1) ES2414808T3 (en)
WO (1) WO2010078900A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010021637A1 (en) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituted 5-fluoro-1H-pyrazolopyridines and their use
DE102010031667A1 (en) * 2010-07-22 2012-01-26 Bayer Schering Pharma Aktiengesellschaft Substituted methyl pyrimidin-5-ylcarbamates and their use
DE102010043379A1 (en) 2010-11-04 2012-05-10 Bayer Schering Pharma Aktiengesellschaft Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use
ES2583086T3 (en) * 2011-04-21 2016-09-19 Bayer Intellectual Property Gmbh Pyrazolopyridines substituted with fluoroalkyl and their use
JP5975025B2 (en) 2011-05-30 2016-08-23 アステラス製薬株式会社 Imidazopyridine compounds
DE102012200360A1 (en) * 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted triazines and their use
KR20140144696A (en) * 2012-04-16 2014-12-19 도아 에이요 가부시키가이샤 Bicyclic compound
CN104822680B (en) 2012-11-30 2016-10-12 安斯泰来制药株式会社 Imidazopyridine
AP2015008670A0 (en) 2013-02-21 2015-08-31 Adverio Pharma Gmbh Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
EP3094327A1 (en) 2014-01-13 2016-11-23 Ironwood Pharmaceuticals, Inc. USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
CA3006764A1 (en) 2015-12-14 2017-06-22 Ironwood Pharmaceuticals, Inc. Use of sgc stimulators for the treatment of gastrointestinal sphincter dysfunction
WO2017121692A1 (en) * 2016-01-15 2017-07-20 Bayer Pharma Aktiengesellschaft Substituted sulfamides and use of same
US20190381039A1 (en) 2016-12-13 2019-12-19 Cyclerion Therapeutics, Inc. USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS
JP7090639B2 (en) 2017-04-11 2022-06-24 サンシャイン・レイク・ファーマ・カンパニー・リミテッド Fluoride-substituted indazole compounds and their use
AR117398A1 (en) 2018-03-12 2021-08-04 Abbvie Inc INHIBITORS OF SIGNALING MEDIATED BY TYROSINE KINASE 2
KR20250141845A (en) 2018-07-11 2025-09-29 티센토 쎄라퓨틱스 인크. USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONRIAL DISORDERS
UY39832A (en) 2021-06-28 2023-01-31 Blueprint Medicines Corp CDK2 INHIBITORS
CN118772140A (en) * 2023-04-07 2024-10-15 四川大学 A class of compounds and their use in treating hDHODH-mediated diseases

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
TW432061B (en) 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
DE69712042T2 (en) 1996-01-22 2002-10-02 Fujisawa Pharmaceutical Co., Ltd. THIAZOLYLBENZOFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE
US6166027A (en) 1996-10-14 2000-12-26 Bayer Aktiengesellschaft Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
DE19642255A1 (en) 1996-10-14 1998-04-16 Bayer Ag Use of 1-benzyl-3- (substituted-hetaryl) fused pyrazole derivatives
DE19649460A1 (en) 1996-11-26 1998-05-28 Bayer Ag New substituted pyrazole derivatives
IL135462A0 (en) 1997-11-12 2001-05-20 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
US6451805B1 (en) 1997-11-14 2002-09-17 Bayer Aktiengesellschaft Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
DE19834044A1 (en) 1998-07-29 2000-02-03 Bayer Ag New substituted pyrazole derivatives
DE19834047A1 (en) 1998-07-29 2000-02-03 Bayer Ag Substituted pyrazole derivatives
DE19834045A1 (en) 1998-07-29 2000-02-03 Bayer Ag (4-Amino-5-ethylpyrimidin-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine
DE19846514A1 (en) 1998-10-09 2000-04-20 Bayer Ag New arylmethyl and heterocyclylmethyl substituted heteroaryl-indazole derivatives useful in treatment of cardiovascular, ischemic and urogenital disorders
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
AR031176A1 (en) 2000-11-22 2003-09-10 Bayer Ag NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE
DE10057754A1 (en) 2000-11-22 2002-05-23 Bayer Ag New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
DE10057751A1 (en) 2000-11-22 2002-05-23 Bayer Ag New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
EP1339716B1 (en) 2000-11-22 2004-11-03 Bayer HealthCare AG lactam-substituted pyrazolopyridine derivatives
DE10122894A1 (en) 2001-05-11 2002-11-14 Bayer Ag New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
DE10132416A1 (en) 2001-07-04 2003-01-16 Bayer Ag New morpholine-bridged pyrazolopyridine derivatives
JP2005510492A (en) 2001-10-26 2005-04-21 ユニバーシティ オブ コネチカット A new class of potent cannabis mimetic ligands
WO2003076408A2 (en) 2002-03-08 2003-09-18 Abbott Laboratories Indazole derivatives that are activators of soluble guanylate cyclase
DE10220570A1 (en) * 2002-05-08 2003-11-20 Bayer Ag Carbamate-substituted pyrazolopyridines
DE10222550A1 (en) 2002-05-17 2003-11-27 Bayer Ag New 1-benzyl-3-(2-pyrimidinyl)-pyrazolo-(3,4-b)-pyridine derivatives are soluble guanylate cyclase stimulants, useful e.g. for treating cardiovascular or thromboembolic diseases or sexual dysfunction
DE10242941A1 (en) 2002-09-16 2004-03-18 Bayer Ag New 2-(pyrazolo-(3,4-b)-pyridinyl)-5-pyridinyl-4-pyrimidinylamine derivative, is a soluble guanylate cyclase stimulant useful e.g. for treating cardiovascular diseases, hypertension or ischemia
DE10244810A1 (en) 2002-09-26 2004-04-08 Bayer Ag New morpholine-bridged indazole derivatives
JP4499721B2 (en) 2003-06-30 2010-07-07 ヒフ バイオ，インク． Compounds, compositions and methods
TWI258478B (en) 2003-10-31 2006-07-21 Arena Pharm Inc Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
DE10351903A1 (en) 2003-11-06 2005-06-09 Bayer Healthcare Ag New combination
GB0327319D0 (en) * 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
US7592348B2 (en) * 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) * 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
GB0403819D0 (en) 2004-02-20 2004-03-24 Merck Sharp & Dohme New compounds
WO2005097799A1 (en) * 2004-04-07 2005-10-20 Pfizer Limited Pyrazolo`4,3-d! pyrimidines
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
TW200738725A (en) * 2006-01-25 2007-10-16 Osi Pharm Inc Unsaturated mTOR inhibitors
DE102006020327A1 (en) * 2006-04-27 2007-12-27 Bayer Healthcare Ag Heterocyclic substituted, fused pyrazole derivatives and their use
DE102006021733A1 (en) 2006-05-09 2007-11-22 Bayer Healthcare Ag 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
DE102006043443A1 (en) 2006-09-15 2008-03-27 Bayer Healthcare Ag Novel aza-bicyclic compounds and their use
DE102009004245A1 (en) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Novel fused, heteroatom-bridged pyrazole and imidazole derivatives and their use
DE102010021637A1 (en) * 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituted 5-fluoro-1H-pyrazolopyridines and their use

Also Published As

Publication number Publication date
US20110245273A1 (en) 2011-10-06
ES2414808T3 (en) 2013-07-22
CA2747305A1 (en) 2010-07-15
EP2379071A2 (en) 2011-10-26
JP2012512207A (en) 2012-05-31
WO2010078900A2 (en) 2010-07-15
US8334291B2 (en) 2012-12-18
CA2747305C (en) 2017-04-18
JP5791110B2 (en) 2015-10-07
DE102008063992A1 (en) 2010-09-02
EP2379071B1 (en) 2013-05-08
WO2010078900A3 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
DE102008063992A8 (en) New aliphatic substituted pyrazolopyridines and their use
PL2504336T3 (en) New naphthyridine derivatives and their use as kinase inhibitors
HRP20190016T1 (en) HETEROCYCLIC COMPOUNDS AND THEIR USE
ATE531712T1 (en) SUBSTITUTED ARYLOXAZOLES AND THEIR USE
EP2427195A4 (en) Heterocyclic compounds and their use
IL239604A0 (en) Antagonists against vegf and their uses
HRP20180718T1 (en) OLIGOPEPTID COMPOUNDS AND THEIR USE
CR20130360A (en) HETEROCYCLIC COMPOUND AND ITS USE
BRPI0914657A2 (en) substituted pyridin-2-one pyridazin-3-ones
ATE546433T1 (en) QUINOLINE DERIVATIVES AND THEIR USE AS FUNGICIDES
HRP20171612T2 (en) NETWORKING JOINTS AND THEIR USE
ATE486856T1 (en) BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX
EP3756767C0 (en) MODULAR POC DEVICES AND THEIR USE
DK2124829T3 (en) Reverse shoulder prosthesis
DK2376490T3 (en) imidazopyridine compounds
DK2276486T3 (en) NEW SUBSTITUTED IMIDAZO QUINOLINES
SMT201500218B (en) Aryl-phenylsulfonamido-cycloalkyl compounds and their use
BRPI0916295A2 (en) tricyclic pyrazolopyridine kinase inhibitors
BRPI0914301A2 (en) substituted pyrimidin-4-one derivatives
FI20086158A0 (en) imidazopyridine
PL2480546T3 (en) Imidazopyridine and imidazopyrimidine derivatives as phosphodiesterase 10A inhibitors
ATE478059T1 (en) CINNAMOYLPIPERAZINE DERIVATIVES AND THEIR USE AS PAR-1 ANTAGONISTS
ATE537149T1 (en) SULFONYL-PYRAZOLINYL-1-CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
ATE547407T1 (en) ALKYLTHIOPYRIMIDINES AS CRTH2 ANTAGONISTS
BRPI1011036A2 (en) use

Legal Events

Date Code Title Description
8196 Reprint of faulty title page (publication) german patentblatt: part 1a6
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20110701